ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 140 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $238,000 | -40.6% | 9,300 | -33.5% | 0.04% | -25.5% |
| Q2 2023 | $401,000 | +19.7% | 13,975 | 0.0% | 0.05% | +11.9% |
| Q1 2023 | $335,000 | -84.0% | 13,975 | -68.1% | 0.04% | -87.7% |
| Q3 2021 | $2,093,000 | +5.2% | 43,800 | -25.5% | 0.34% | +15.6% |
| Q2 2021 | $1,990,000 | +140.9% | 58,800 | +194.0% | 0.30% | +109.2% |
| Q1 2021 | $826,000 | – | 20,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |